Vagal Nerve Stimulation Markedly Improves Long-Term Survival After Chronic Heart Failure in Rats

Background—Diminished cardiac vagal activity and higher heart rate predict a high mortality rate of chronic heart failure (CHF) after myocardial infarction. We investigated the effects of chronic electrical stimulation of the vagus nerve on cardiac remodeling and long-term survival in an animal model of CHF after large myocardial infarction. Methods and Results—Two weeks after the ligation of the left coronary artery, surviving rats were randomized to vagal- and sham-stimulated groups. Using an implantable miniature radio-controlled electrical stimulator, we stimulated the right vagal nerve of CHF rats for 6 weeks. The intensity of electrical stimulation was adjusted for each rat, so that the heart rate was lowered by 20 to 30 beats per minute. The treated rats had significantly lower left ventricular end-diastolic pressure (17.1±5.9 versus 23.5±4.2 mm Hg, P <0.05) and higher maximum dp/dt of left ventricular pressure (4152±237 versus 2987±192 mm Hg/s, P <0.05) than the untreated rats. Improvement of cardiac pumping function was accompanied by a decrease in normalized biventricular weight (2.75±0.25 versus 3.14±0.22 g/kg, P <0.01). Although the 140-day survival of the untreated group was only half, vagal stimulation markedly improved the survival rate (86% versus 50%, P =0.008). Vagal stimulation therapy achieved a 73% reduction in a relative risk ratio of death. Conclusions—Vagal nerve stimulation markedly improved the long-term survival of CHF rats through the prevention of pumping failure and cardiac remodeling.

[1]  M. A. Plant Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality , 1991 .

[2]  M. Sugimachi,et al.  The brain is a possible target for an angiotensin-converting enzyme inhibitor in the treatment of chronic heart failure. , 1998, Journal of cardiac failure.

[3]  J. Cohn,et al.  A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. , 2001, The New England journal of medicine.

[4]  Jerome V. Murphy,et al.  Stimulation of the Nervous System for the Management of Seizures , 2003, CNS drugs.

[5]  S. Reid Surgical Technique for Implantation of the Neurocybernetic Prosthesis , 1990, Epilepsia.

[6]  P. Douglas,et al.  Serial echocardiographic assessment of left ventricular geometry and function after large myocardial infarction in the rat. , 1994, Circulation.

[7]  P. Schwartz,et al.  Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification. , 1992, Circulation.

[8]  P. Saxena,et al.  Low-dose aspirin improves in vivo hemodynamics in conscious, chronically infarcted rats. , 1998, Cardiovascular research.

[9]  M. Pfeffer Left ventricular remodeling after acute myocardial infarction. , 1995, Annual review of medicine.

[10]  G. Zhao,et al.  Selective impairment of vagally mediated, nitric oxide-dependent coronary vasodilation in conscious dogs after pacing-induced heart failure. , 1995, Circulation.

[11]  D. Mann Tumor necrosis factor-induced signal transduction and left ventricular remodeling. , 2002, Journal of cardiac failure.

[12]  Masaru Sugimachi,et al.  Bionic Technology Revitalizes Native Baroreflex Function in Rats With Baroreflex Failure , 2002, Circulation.

[13]  M. Pfeffer,et al.  Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. , 1985, Circulation.

[14]  Effect of carvedilol on survival in severe chronic heart failure. , 2001 .

[15]  S. Dhein,et al.  Muscarinic receptors in the failing human heart. , 1999, European journal of pharmacology.

[16]  J. Smits,et al.  Time-related adaptations in plasma neurohormone levels and hemodynamics after myocardial infarction in the rat. , 1998, Journal of cardiac failure.

[17]  P. Douglas,et al.  Effects of propranolol treatment on left ventricular function and intracellular calcium regulation in rats with postinfarction heart failure , 1999, British journal of pharmacology.

[18]  P. Schwartz,et al.  Single cardiac vagal fiber activity, acute myocardial ischemia, and risk for sudden death. , 1991, Circulation research.

[19]  M. Sugimachi,et al.  Increased brain angiotensin receptor in rats with chronic high-output heart failure. , 2000, Journal of cardiac failure.

[20]  A. Mallet,et al.  Heart Rate and Cardiac Rhythm Relationships With Bisoprolol Benefit in Chronic Heart Failure in CIBIS II Trial , 2001, Circulation.

[21]  G Cooper,et al.  Bradycardia and the role of beta-blockade in the amelioration of left ventricular dysfunction. , 2000, Circulation.

[22]  A. Zamotrinsky,et al.  Vagal neurostimulation in patients with coronary artery disease , 2001, Autonomic Neuroscience.

[23]  L. Minutoli,et al.  Efferent Vagal Fibre Stimulation Blunts Nuclear Factor-&kgr;B Activation and Protects Against Hypovolemic Hemorrhagic Shock , 2003, Circulation.

[24]  K Sagawa,et al.  Ventricular efficiency predicted by an analytical model. , 1986, The American journal of physiology.

[25]  A. Mark Sensitization of cardiac vagal afferent reflexes at the sensory receptor level: an overview. , 1987, Federation proceedings.

[26]  S. Goldman,et al.  Ventricular remodeling in heart failure. , 2002, Journal of cardiac failure.

[27]  Markel' Al Sensitization of cardiac vagal afferent reflexes at the sensory receptor level: an overview. , 1987 .

[28]  B. Pitt,et al.  The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. , 1999, The New England journal of medicine.

[29]  B. Pitt,et al.  The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure , 2000 .

[30]  S. S. Hull,et al.  Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. , 1991, Circulation research.

[31]  J. Bigger,et al.  Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction , 1998, The Lancet.

[32]  S. Yusuf,et al.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. , 2000 .

[33]  K. Swedberg,et al.  Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. , 1990, Circulation.

[34]  N. Hollenberg,et al.  Literature alert , 2002 .

[35]  J. Oss,et al.  PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .

[36]  J. Sanderson,et al.  Effect of carvedilol in comparison with metoprolol on myocardial collagen postinfarction. , 2000, Journal of the American College of Cardiology.